Replicate Bioscience
PrivateLast Round
Grant
Jun 19, 2026
Total Funding Raised
$49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Replicate Bioscience is a biotechnology company that develops self-replicating RNA (srRNA) immunotherapies for the treatment of cancer, infectious diseases, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Replicate Bioscience Comparables
Compare Replicate Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimeron Bio | 83% | |
| Strand Therapeutics | 83% | |
| Bristol Myers Squibb | 82% | |
Replicate Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 19, 2026 | ||||
| Series A | Sep 8, 2021 | ||||
| Seed | Feb 16, 2021 | ||||
| Seed | Jun 24, 2020 |
Key People
Founding team and executive leadership
Replicate Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A, Seed |
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Secured $7M in grant funding.
- Jan 8, 2026
Developing self-replicating RNA vaccines for HIV and malaria.
Replicate Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Replicate Bioscience's valuation, stock price, and market status.